FR2398488A1 - Matiere artificielle a usage medical douee d'activite anticoagulante - Google Patents

Matiere artificielle a usage medical douee d'activite anticoagulante

Info

Publication number
FR2398488A1
FR2398488A1 FR7822277A FR7822277A FR2398488A1 FR 2398488 A1 FR2398488 A1 FR 2398488A1 FR 7822277 A FR7822277 A FR 7822277A FR 7822277 A FR7822277 A FR 7822277A FR 2398488 A1 FR2398488 A1 FR 2398488A1
Authority
FR
France
Prior art keywords
medical use
anticoagulant activity
artificial material
artificial
anticoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7822277A
Other languages
English (en)
Other versions
FR2398488B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2398488A1 publication Critical patent/FR2398488A1/fr
Application granted granted Critical
Publication of FR2398488B1 publication Critical patent/FR2398488B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une matière artificielle à usage médical douée d'activité anticoagulante. La matière artificielle anticoagulante selon l'invention comprend un matériau de support sur lequel de l'héparine et de l'antithrombine III sont fixées ensemble par une technique classique. Application : la matière selon l'invention est utile pour empêcher la coagulation du sang.
FR7822277A 1977-07-27 1978-07-27 Matiere artificielle a usage medical douee d'activite anticoagulante Granted FR2398488A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52090673A JPS6040859B2 (ja) 1977-07-27 1977-07-27 抗血栓性人工医療材料

Publications (2)

Publication Number Publication Date
FR2398488A1 true FR2398488A1 (fr) 1979-02-23
FR2398488B1 FR2398488B1 (fr) 1983-02-18

Family

ID=14005048

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7822277A Granted FR2398488A1 (fr) 1977-07-27 1978-07-27 Matiere artificielle a usage medical douee d'activite anticoagulante

Country Status (7)

Country Link
US (1) US4213962A (fr)
JP (1) JPS6040859B2 (fr)
CA (1) CA1116087A (fr)
DE (1) DE2832536A1 (fr)
FR (1) FR2398488A1 (fr)
GB (1) GB2001528B (fr)
SE (1) SE447628B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002426A1 (fr) * 1979-05-04 1980-11-13 Merieux Inst Concentres de complexe prothrombinique, preparation et application
FR2460138A1 (fr) * 1978-01-07 1981-01-23 Green Cross Corp Preparation antithrombinique et son procede de fabrication

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
USRE35770E (en) * 1978-11-06 1998-04-14 Choay, S.A. Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4826827A (en) * 1979-10-05 1989-05-02 Choay S.A. Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
DE3329733A1 (de) * 1983-08-17 1985-03-07 Johannes Dr.med. 6500 Mainz Reinmüller Kunststoff-implantat
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
US5262451A (en) * 1988-06-08 1993-11-16 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5182317A (en) * 1988-06-08 1993-01-26 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5342693A (en) * 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
WO2001070289A2 (fr) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Microspheres injectables, susceptibles de foisonnement, visant a faire gonfler un tissu
DE102021112467B4 (de) 2021-05-12 2023-03-02 Technische Universität Hamburg Synthetisches Thrombusmodell zum Erlernen der operativen Entfernung eines Blutgerinnsels im Rahmen einer Behandlungsnachstellung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2109951A5 (fr) * 1970-10-05 1972-05-26 Incentive Ab
FR2347686A1 (fr) * 1974-12-09 1977-11-04 Rimbaud Marie Tube a prelevement pour le dosage de la glycemie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5515222B2 (fr) * 1972-08-18 1980-04-22
JPS5236779A (en) * 1975-09-18 1977-03-22 Showa Electric Wire & Cable Co Ltd Electromagnetic shielding cable
US4048064A (en) * 1976-04-23 1977-09-13 Clark Iii William T Biocompatible hemoperfusion system
US4073723A (en) * 1976-11-15 1978-02-14 Swank Roy L Anti-coagulating and filtering blood

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2109951A5 (fr) * 1970-10-05 1972-05-26 Incentive Ab
FR2347686A1 (fr) * 1974-12-09 1977-11-04 Rimbaud Marie Tube a prelevement pour le dosage de la glycemie

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CA1971 *
CA1972 *
CA1975 *
CA1978 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460138A1 (fr) * 1978-01-07 1981-01-23 Green Cross Corp Preparation antithrombinique et son procede de fabrication
WO1980002426A1 (fr) * 1979-05-04 1980-11-13 Merieux Inst Concentres de complexe prothrombinique, preparation et application
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus

Also Published As

Publication number Publication date
FR2398488B1 (fr) 1983-02-18
GB2001528A (en) 1979-02-07
SE447628B (sv) 1986-12-01
DE2832536A1 (de) 1979-02-15
US4213962A (en) 1980-07-22
CA1116087A (fr) 1982-01-12
JPS5424478A (en) 1979-02-23
DE2832536C2 (fr) 1988-04-21
GB2001528B (en) 1982-01-06
SE7808161L (sv) 1979-01-28
JPS6040859B2 (ja) 1985-09-12

Similar Documents

Publication Publication Date Title
FR2398488A1 (fr) Matiere artificielle a usage medical douee d'activite anticoagulante
DE69005845D1 (de) Diaphragmaaufbau eines Verdichters.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
IT8048102A0 (it) Procedimento di preparazione di un idrolisato di proteine purificato
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DK0703897T3 (da) Lipoxinforbindelser med forlænget halveringstid
ES2039709T3 (es) Un procedimiento para preparar una composicion anticoagulante.
NL184768B (nl) Zuiginstrument voor chirurgische doeleinden.
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
IT9041529A0 (it) Dispositivo per la correzione chirurgica dell'ametropia
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
DK453387D0 (da) Middel til behandling af arteriosklerose og forhindring af blodpladekoagulation
NO153005C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte diamino-heptynderivater.
ATE57681T1 (de) Carboxanilide.
SU628197A1 (ru) Состав дл получени волокнистого материала
IT9020113A0 (it) Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv
KR880701886A (ko) 췌장효소원의 유리활성화 펩티드의 면역검정에 의한 질병의 진단, 위중도 예견, 및 모니터링
IT1100101B (it) Racemizzazione dell'estere di una lisina otticamente attivo
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
FI903637A0 (fi) Diagnostiska analysfoerfarande och deras anvaendning foer bestaemning av kliniska tillstaond.

Legal Events

Date Code Title Description
ST Notification of lapse